Allergy & Immunology Doctors in Silver Spring, MD Accepting Medicare

7 Allergy & Immunology doctors found. Showing 1 - 7

Angela Renae Canady, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2101 Medical Park Dr Ste 305, Silver Spring, MD 20902 Phone: 301-681-6055

Eileen M Marin, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 10301 Georgia Ave, Ste 306, Silver Spring, MD 20902 Phone: 301-681-6055    Fax: 301-681-9670

Martin R. Correa, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10301 Georgia Ave Ste 306, Silver Spring, MD 20902 Phone: 013-681-9670    Fax: 301-681-6055

Dr. Geoffrey W Rake Jr., M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1335 E West Hwy, Suite 6-100, Silver Spring, MD 20910 Phone: 301-295-8127

Dr. Vasif Cuneyt Kalfa Sr., MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8630 Fenton St Ste 522, Silver Spring, MD 20910 Phone: 240-531-2902    Fax: 240-847-7061

Dr. D'jahna Thomas, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2415 Musgrove Rd, Suite 107, Silver Spring, MD 20904 Phone: 301-879-7700

Edward Stanley Yanowitz, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 10801 Lockwood Dr Ste 180, Silver Spring, MD 20901 Phone: 301-587-1127    Fax: 301-587-1129

News Archive

Genetic testing is cost-effective, beneficial for newly diagnosed patients with metastatic GIST

Because gastrointestinal stromal tumors (GIST) are sensitive to the targeted small molecule therapy imatinib, oncologists tend to treat all patients with metastatic GIST with this drug. However, because this rare type of cancer is caused by different genetic mutations, imatinib does not help all patients equally.

Helsinn one step closer to bringing anamorelin HCI to market for treatment of anorexia, cachexia in NSCLC patients

Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announced that the European Medicines Agency accepted for review, the marketing authorization application (MAA) for anamorelin HCI, a novel, orally active selective ghrelin receptor agonist under development for the treatment of anorexia, cachexia, or unintended weight loss in non-small cell lung cancer (NSCLC) patients.

CVS Caremark survey results of specialty pharmacy patients

CVS Caremark today announced results of a survey of the company's specialty pharmacy patients that provides insights into their views on medication adherence and their perceptions about the role of their specialty pharmacy. The survey results show nearly 70 percent of respondents believe their specialty pharmacy team played an important role in encouraging them to take their specialty medications as prescribed.

Aggressive medical treatment without stenting better for high-risk stroke patients

An article appearing in the Sept. 7 New England Journal of Medicine, reporting on National Institutes of Health research on brain stents, says aggressive medical treatment without stenting is better for high-risk stroke patients.

Read more Medical News

› Verified 7 days ago